This was the stock's fourth consecutive day of gains.
The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...
This was the stock's third consecutive day of gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback